Literature DB >> 1691308

Mapping of the Alz 50 epitope in microtubule-associated proteins tau.

H Ksiezak-Reding1, C H Chien, V M Lee, S H Yen.   

Abstract

Alz 50 and seven other monoclonal antibodies have been shown to react with both tau and Alzheimer brain proteins of molecular mass 60-70 kDa. The location of some of the epitopes of these antibodies (Alz 50, Tau-2, NP14, Ab 636.7) on the tau molecule is unknown, whereas those of others (Tau 60, Tau 14, Tau-1, Tau 46) have recently been demonstrated in fetal human tau at amino acid residues 60-72, 83-120, 131-140, and 315-352. To determine the location of the unknown epitopes, human tau was digested with chymotrypsin and trypsin, and the bovine microtubule fraction was incubated with chymotrypsin. Comparison of the immunoblots of chymotryptic digested tau with those of untreated preparations showed that the Alz 50 epitope was more sensitive than other tau epitopes to proteolysis. Cleavage of a 3-4 kDa polypeptide from the periphery of tau was sufficient to remove the Alz 50 epitope, but not the epitopes of Tau 46 (C-end) or Tau 60 (N-end). The distribution of the Alz 50 epitope in endogenously degraded, chymotrypsin or trypsin digested tau fragments was different from that of the Tau 46 epitope known to be located within 38 residues from the C-terminus of the tau molecule. Based on these observations Alz 50 epitope was considered to be located within 3-4 kDa of the N-terminus of tau. A comparison of immunoblots of different tau-reactive antibodies showed similarities between Tau 60 and Tau-2, and between Tau 14, Tau-1, NP14, and Ab 636.7.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1691308     DOI: 10.1002/jnr.490250319

Source DB:  PubMed          Journal:  J Neurosci Res        ISSN: 0360-4012            Impact factor:   4.164


  15 in total

1.  Selective destruction of stable microtubules and axons by inhibitors of protein serine/threonine phosphatases in cultured human neurons.

Authors:  S E Merrick; J Q Trojanowski; V M Lee
Journal:  J Neurosci       Date:  1997-08-01       Impact factor: 6.167

2.  The N terminal region of human tau is present in Alzheimer's disease protein A68 and is incorporated into paired helical filaments.

Authors:  A Crowe; H Ksiezak-Reding; W K Liu; D W Dickson; S H Yen
Journal:  Am J Pathol       Date:  1991-12       Impact factor: 4.307

3.  Proteasome degradation of brain cytosolic tau in Alzheimer's disease.

Authors:  Samuel S Yen
Journal:  Int J Clin Exp Pathol       Date:  2011-04-28

4.  Widespread cytoskeletal pathology characterizes corticobasal degeneration.

Authors:  M B Feany; D W Dickson
Journal:  Am J Pathol       Date:  1995-06       Impact factor: 4.307

Review 5.  Probing modifications of the neuronal cytoskeleton.

Authors:  L C Doering
Journal:  Mol Neurobiol       Date:  1993 Fall-Winter       Impact factor: 5.590

6.  Difference between the tau protein of Alzheimer paired helical filament core and normal tau revealed by epitope analysis of monoclonal antibodies 423 and 7.51.

Authors:  M Novak; R Jakes; P C Edwards; C Milstein; C M Wischik
Journal:  Proc Natl Acad Sci U S A       Date:  1991-07-01       Impact factor: 11.205

7.  Epitope map of neurofilament protein domains in cortical and peripheral nervous system Lewy bodies.

Authors:  M L Schmidt; J Murray; V M Lee; W D Hill; A Wertkin; J Q Trojanowski
Journal:  Am J Pathol       Date:  1991-07       Impact factor: 4.307

8.  Ultrastructure and biochemical composition of paired helical filaments in corticobasal degeneration.

Authors:  H Ksiezak-Reding; K Morgan; L A Mattiace; P Davies; W K Liu; S H Yen; K Weidenheim; D W Dickson
Journal:  Am J Pathol       Date:  1994-12       Impact factor: 4.307

9.  Alz-50 and ubiquitin immunoreactivity is induced by permanent focal cerebral ischaemia in the cat.

Authors:  D Dewar; D I Graham; G M Teasdale; J McCulloch
Journal:  Acta Neuropathol       Date:  1993       Impact factor: 17.088

10.  Immunohistochemical and histopathologic correlates of Alzheimer's disease-associated Alz-50 immunoreactivity quantified in homogenates of cerebral tissue.

Authors:  S M de la Monte; R A Spratt; J Chong; H A Ghanbari; J R Wands
Journal:  Am J Pathol       Date:  1992-12       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.